Wednesday, March 4, 2015

Daniel Hoffman

What's driving the pharmaceutical industry's drug development process?

Tuesday, February 18, 2014, 6:00 AM
Over the last several years some widely discernible trends of the pharmaceutical industry's drug development process have emerged. Much of this is driven by three factors. The first is that a declining percentage of the drugs produced by research constitute genuine breakthroughs capable of substantially... Read more

Drug prices: Higher and higher

Thursday, January 30, 2014, 11:59 AM
In an effort save money on continually rising drug costs, the Germans passed the Reform of the Market for Medicinal Products act in 2010 to assess whether newly approved brands in that country justify their higher prices with greater benefits than older products. Germany's Federal Joint Committee... Read more

Pharma's 2014 outlook and Merck's changing culture

Monday, January 20, 2014, 10:35 AM
Citigroup recently issued its 2014 outlook for European and US pharmaceutical companies. While their outlook is generally bullish, the positive signs they emphasize for the industry are more notable for what they omit than for what they tout. For example, some of their up-indicators include a more... Read more

Challenges for Merck's Venture in Weight Loss Management

Thursday, January 9, 2014, 6:00 AM
In the week before Christmas, Merck announced (see here) that it was starting a weight loss business as a self-supporting enterprise. In the past, whenever pharmas launched businesses outside of prescription and non-prescription pharmaceuticals, they were typically "value-added" enterprises designed... Read more

A lesson from not prosecuting the banks

Tuesday, December 31, 2013, 6:00 AM
Anyone who's been awake the past five years knows that the U.S. experienced its worst economic recession since the 1930s as a result of fraudulent manipulations by investment banks and other financial institutions. Equally galling has been the lack of criminal action against these Wall Street fraudsters... Read more

A step in the right direction for Pharma

Thursday, December 26, 2013, 9:45 AM
Given pharma's way of doing business during the past decade, it’s become extremely difficult to identify emerging patterns that deserve an attaboy. That’s all the more reason to commend GlaxoSmithKline’s management for two steps they took last week. The company’s CEO, Andrew... Read more

Doing good by doing well: A career opportunity in Pharma

Tuesday, December 17, 2013, 6:00 AM
Pharma is no longer the industry it once was. R&D managers now dance to the tune of finance/accounting and lawyers on the industry’s most important function: developing new therapies. More generally, although pharma is an industry whose goal consists of creating products to improve the... Read more

Pharma offers opportunity for progressive change

Monday, December 9, 2013, 10:04 AM
In 2009 pharma cut a deal with the Obama administration that called for the industry to refrain from opposing the Affordable Care Act (ACA) and subsidize the prescription drug coverage of seniors under Medicare Part D. Prior to ACA, Medicare recipients faced the full "donut hole" burden that required... Read more

Pharma goes to court to defend high prices, deceptive marketing

Monday, December 2, 2013, 6:00 AM
Earlier this month the online pharmacy information company, PharmacyChecker.com, compared prices on fifteen of the top-selling brand name medications made in the U.S. (see here). They found that U.S. consumers can save an average of 76% on these domestically produced products by buying them from verified... Read more

Pharma not prepared for changing health care landscape

Thursday, November 21, 2013, 6:00 AM
Public attention for the last few weeks has rightly focused on the inexcusable mistakes that accompanied the Affordable Care Act's rollout. While the pharmaceutical industry spent several years preparing for the ACA, managements at most of the companies remain flatfooted amidst a few other trends... Read more
About this blog

Check Up covers regional health news and a wide array of healthcare topics from pharmaceutical happenings to patient safety. Read about some of our bloggers here.

Portions of this blog may also be found in the Inquirer's Sunday Health Section.

Michael R. Cohen, R.Ph. President, Institute for Safe Medication Practices
Daniel R. Hoffman, Ph.D. President, Pharmaceutical Business Research Associates
Hooman Noorchashm, M.D., Ph.D. Cardiothoracic surgeon in the Philadelphia area
Amy J. Reed, M.D., Ph.D. Anesthesiologist and Surgical Intensivist in the Philadelphia Area
Latest Health Videos
Also on Philly.com:
Stay Connected